The unprecedented rapid deployment of mRNA vaccines against COVID-19 can be traced back to the early studies of RNA nanocarriers, including the study by Zimmermann et al. which showcased the effectiveness of RNA nanocarriers in vivo. This study, among others, ultimately resulted in Onpattro, the first FDA-approved RNA formulation.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9811353 | PMC |
| http://dx.doi.org/10.1016/j.tibtech.2022.12.019 | DOI Listing |
Publication Analysis
Top Keywords
rna nanocarriers
12
rna
4
nanocarriers generation
4
generation drug
4
drug delivery
4
delivery platform
4
platform center
4
center stage
4
stage unprecedented
4
unprecedented rapid
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!